GH1 and type 2 diabetes mellitus: In a subset of adult GHD patients with a propensity toward development of T2D, such as obesity and/or family history of T2D, GH therapy can be associated with the development of glucose intolerance or T2D in the first year of therapy (4), so monitoring with HbA1c is important.